Reporting owner
David Matthew T
Reporting owner CIK 0001811612 · Chief Financial Officer
These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 14, 2026 | Actinium Pharmaceuticals, Inc.Stock Option (right to purchase) | David Matthew T | Stock award |
| Oct 14, 2026 | Actinium Pharmaceuticals, Inc.Common Stock | David Matthew T | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transactions in associated filings
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Trade: | Actinium Pharmaceuticals, Inc.ATNM · company listings | David Matthew TChief Financial Officer | Stock awardStock Option (right to purchase)Derivative security · Code A | 250,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Actinium Pharmaceuticals, Inc.ATNM · company listings | David Matthew TChief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 250,000 | 0Value: 0Currency not specified | View ↗ |
2 transactions on this page. Filing date, newest first.